Kezar Life Sciences Stock Alpha and Beta Analysis

KZR Stock  USD 6.48  0.05  0.78%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Kezar Life Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Kezar Life over a specified time horizon. Remember, high Kezar Life's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Kezar Life's market risk premium analysis include:
Beta
0.2
Alpha
(0.32)
Risk
2
Sharpe Ratio
(0.07)
Expected Return
(0.13)
Please note that although Kezar Life alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Kezar Life did 0.32  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Kezar Life Sciences stock's relative risk over its benchmark. Kezar Life Sciences has a beta of 0.20  . As returns on the market increase, Kezar Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kezar Life is expected to be smaller as well. At this time, Kezar Life's Book Value Per Share is relatively stable compared to the past year. As of 02/01/2025, Tangible Book Value Per Share is likely to grow to 2.49, while Enterprise Value Multiple is likely to drop (6.38).

Enterprise Value

732.55 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Kezar Life Backtesting, Kezar Life Valuation, Kezar Life Correlation, Kezar Life Hype Analysis, Kezar Life Volatility, Kezar Life History and analyze Kezar Life Performance.

Kezar Life Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Kezar Life market risk premium is the additional return an investor will receive from holding Kezar Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Kezar Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Kezar Life's performance over market.
α-0.32   β0.20

Kezar Life expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Kezar Life's Buy-and-hold return. Our buy-and-hold chart shows how Kezar Life performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Kezar Life Market Price Analysis

Market price analysis indicators help investors to evaluate how Kezar Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kezar Life shares will generate the highest return on investment. By understating and applying Kezar Life stock market price indicators, traders can identify Kezar Life position entry and exit signals to maximize returns.

Kezar Life Return and Market Media

The median price of Kezar Life for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 is 6.89 with a coefficient of variation of 7.35. The daily time series for the period is distributed with a sample standard deviation of 0.51, arithmetic mean of 6.96, and mean deviation of 0.45. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Glancy Prongay Murray LLP Announces Investigation of Kezar Life Sciences, Inc.
11/05/2024
2
Digging deep for antimony
11/12/2024
3
Kezar Life Sciences Given New 11.00 Price Target at Wells Fargo Company - MarketBeat
11/14/2024
4
Acquisition by Christopher Kirk of 48950 shares of Kezar Life at 0.9 subject to Rule 16b-3
11/21/2024
5
HC Wainwright Issues Pessimistic Outlook for KZR Earnings
12/04/2024
6
Kalamazoo a step closer to 30m payday after big drill results
12/09/2024
7
Resources Top 5 Kalamazoo leads as Mallina West gold assays loom
01/07/2025
8
Acquisition by Christopher Kirk of 120000 shares of Kezar Life at 6.58 subject to Rule 16b-3
01/08/2025
9
Acquisition by Klearman Micki of 52000 shares of Kezar Life at 2.28 subject to Rule 16b-3
01/15/2025
10
Resources Top 6 Gold explorers look for proof in the pudding as prices get drill rigs moving
01/21/2025

About Kezar Life Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Kezar or other stocks. Alpha measures the amount that position in Kezar Life Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Payables Turnover0.150.14
Days Of Inventory On Hand543.87377.62

Kezar Life Upcoming Company Events

As portrayed in its financial statements, the presentation of Kezar Life's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kezar Life's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Kezar Life's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Kezar Life. Please utilize our Beneish M Score to check the likelihood of Kezar Life's management manipulating its earnings.
12th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Kezar Life

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.